Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Dettagli Bibliografici
Autore principale:	Tania, Umme
Altri autori:	Khan, Tanisha
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2023
Soggetti:	Biologics Biosimilars Bevacizumab Non-small cell lung cancer Regulatory frameworks Targeted therapy Lungs > Cancer
Accesso online:	http://hdl.handle.net/10361/18736

Documenti analoghi

A review on targeted therapies for lung cancer
di: Ashraf, Anushey
Pubblicazione: (2023)

Molecules associated with the development of lung cancer
di: Rahman, Adree, et al.
Pubblicazione: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
di: Paul, Pulock
Pubblicazione: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
di: Jeba, Joynob
Pubblicazione: (2017)

Potential of liposomes for the treatment of lung cancer- a review
di: Mim, Shanzida
Pubblicazione: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
di: Rahman, Tasnim
Pubblicazione: (2024)

Biosimilar in lymphoma treatment
di: Tanisha, Mehrin Haque
Pubblicazione: (2021)

A review on recent advances in drugs for lung cancer treatment
di: Noor, Fouzia
Pubblicazione: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
di: Hoque, Ismoth Ara
Pubblicazione: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
di: Razna, Amrin Islam
Pubblicazione: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
di: Bristy, Israt Zerin
Pubblicazione: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
di: Shabnam, Musharrat
Pubblicazione: (2018)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
di: Pial, Sazia Afrin
Pubblicazione: (2018)

Immunotherapy in the Management of Lung Cancer
di: Tasnim, Humayra
Pubblicazione: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
di: Zangmo, Thinley
Pubblicazione: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
di: Nandy, Aditi
Pubblicazione: (2022)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
di: Alam, Kazi Tasnuva
Pubblicazione: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
di: Das, Reshita
Pubblicazione: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
di: Tania, Umme
Pubblicazione: (2021)

Lung cancer detection and classification using machine learning
di: Arefin, Mahbubul, et al.
Pubblicazione: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
di: Mukti, Roushney Fatima, et al.
Pubblicazione: (2016)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Karim, Samia Binte
Pubblicazione: (2024)

Stem cells as therapeutic carrier in cancer treatment
di: Anika, Mysha Yeasmin
Pubblicazione: (2022)

SIRT6 and cancer stem cells: is there any implication?
di: Sarker, Tanosi
Pubblicazione: (2022)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
di: Nawar, Anika
Pubblicazione: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
di: Nahar, Kamrun
Pubblicazione: (2023)

Biologics and Biosimilars as Treatment Options for Psoriasis
di: Moya, Amena Khatun
Pubblicazione: (2023)

Targeting BRAFV600E in the treatment of CRC
di: Roja, Mashwiyat Samrin
Pubblicazione: (2024)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
di: Pecorino, Lauren
Pubblicazione: (2012)

Trend in approval of targeted biologics in the last two decades
di: Siddika, Khadiza
Pubblicazione: (2024)

Dendritic cell vaccine for the treatment of cancer
di: Haque, Tanzila
Pubblicazione: (2023)

Biosimilars: A revolution for biologics in the pharmaceutical industry
di: Moreino, Shannon Sherwin
Pubblicazione: (2018)

Stem cell in cancer disease cure vs cause
di: Chowdhury, Marisha Mansur
Pubblicazione: (2023)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
di: F. S. Amaral, André, et al.
Pubblicazione: (2017)

RIPK pathway, as a potential target, for cancer treatment - a review
di: Jahan, Nusrat
Pubblicazione: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
di: Emon, Kamrul Hasan
Pubblicazione: (2022)

CAR-T cell Therapy in B-cell Lymphoma
di: Faruk, Asef
Pubblicazione: (2020)

Biosimilar insulins: a potential option in the treatment of Diabetes
di: Tabassum, Turana
Pubblicazione: (2022)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
di: Auvy, Akib Al Mahmud, et al.
Pubblicazione: (2023)